I have been poking around the patent databases and some publications around phenotypic screening ...
I am forming a view of the potential for the Phenomica jv with the Hutchinson Cambridge University group.
Let me speculate ...
I reckon their big target is cancer.
They are developing Phylomer based screening technologies to pinpoint cells on a phenotypical basis. This means that they can pick out cancer cells, of a tissue type, in a specific individual. (The screening technology patents have been awarded).
If you have the ability to pinpoint cancer cells, and you have the EET technology to deliver a poison ... you have a world beating oncology drug.
Expect some surprises from this Phenomica unit. How close they are, I really don't know ... but I reckon that this is the direction they are heading.
Pure speculation, of course.
I have been poking around the patent databases and some...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $606.5M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 13.5¢ | 12.5¢ | $17.86K | 137.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 1081168 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 505604 | 2 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |